RxDoctor Payments Data

Stephen Wright

Nurse Practitioner · Roanoke, VANPI 1053901934

Payments from drug & device makers

$872in general payments, 2019–2025

Across 37 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kestra Medical Technology Services, Inc.$189
  • Amgen$137
  • Pfizer$113
  • Medtronic$74
  • Atricure, Inc.$73
  • Baxter Healthcare$64
  • plus $223 from 9 others

What the payments were for

  • Food & beverage$872100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$872 in reported general payments places this provider in the 80th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$28,731
Medicare patients
228
Services billed
425

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$45,366
EntrestoSacubitril/Valsartan14$16,022
XareltoRivaroxaban16$14,602
BrilintaTicagrelor21$14,514
Ranolazine ErRanolazine18$1,330
Metoprolol Succinate74$803
Amlodipine Besylate63$414
Atorvastatin Calcium45$406
Carvedilol37$350
Losartan Potassium34$313
Furosemide41$196
ClopidogrelClopidogrel Bisulfate19$159
Metoprolol Tartrate32$155
Lisinopril29$135
Spironolactone16$114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$113$45,36651 claims
NovartisEntresto$27$16,02214 claims
Johnson & JohnsonXarelto$13$14,60216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →